Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...

Zolbetuximab — now with the brand name Vyloy — is a monoclonal antibody to treat patients with advanced gastric and ...

Chronic and acute graft-versus-host disease are managed differently, affect different organs, and impact patients in ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

The CDC’s Timothy M. Uyeki, M.D, however, cautioned that if the virus changes, and especially if it begins to infect pigs, ...

One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Research might produce treatments of involving transplants with a few, selected types of bacteria tailored to an individual's ...

IJ Anosike, M.D., M.P.H., assistant professor of pediatrics at the Montefiore Medical Center in the Bronx, explains how COVID ...

After expansion of Medicaid, there was a significant decrease in the low-income population with no healthcare coverage.

There have been developments in LASIK surgery improving outcomes for patients. George O. Waring, IV, M.D., founder and medical director of the Waring Vision Institute, discussed how new technology ...

Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at ...